Breaking News

CMC Acquires XOMA Manufacturing Site

Berkeley site includes bioreactors, purification suites

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

CMC Biologics has acquired XOMA’s large-scale manufacturing operations and affiliated assets located in Berkeley, CA. Financial terms of the transaction were not disclosed. The fully functional 31,000-sq.-ft. facility is a completely equipped biological manufacturing operation, including three 2,750L stainless steel bioreactors and two purification suites, as well as warehouse and office space. CMC Biologics expects to begin offering CMO services from this location immediately following t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters